Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.50 |
| ▸ | TSHR | P16473 | 3/20 | 0.46 |
| ▸ | TP53 | P04637 | 1/20 | 0.42 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.41 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.41 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.41 |
| ▸ | PHF8 | Q9UPP1 | 1/20 | 0.37 |
| ▸ | KDM2A | Q9Y2K7 | 1/20 | 0.37 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
| ▸ | NPC1 | O15118 | 1/20 | 0.31 |
| ▸ | RAB9A | P51151 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1191256 | 0.85 | ALDH1A1 (0.63) | ALDH1A1TSHRCHRNB2CHRNB4CHRNA4 | |
| SCHEMBL43375 | 0.74 | — | — | |
| SCHEMBL16816192 | 0.74 | ALDH1A1 (0.52) | ALDH1A1TSHRCHRNB2CHRNB4CHRNA4 | |
| SCHEMBL322794 | 0.74 | PHF8 (0.64) | ALDH1A1CHRNB2CHRNB4CHRNA4PHF8 | |
| SCHEMBL1428429 | 0.74 | — | — | |
| SCHEMBL10578272 | 0.74 | ALDH1A1 (0.52) | ALDH1A1TSHRCHRNB2CHRNB4CHRNA4 | |
| SCHEMBL1071900 | 0.74 | ALDH1A1 (0.59) | ALDH1A1TSHRCHRNB2CHRNB4CHRNA4 | |
| SCHEMBL131476 | 0.73 | ALDH1A1 (0.74) | ALDH1A1CHRNB2CHRNB4CHRNA4PHF8 | |
| SCHEMBL5948495 | 0.73 | ALDH1A1 (0.74) | ALDH1A1TSHRCHRNB2CHRNB4CHRNA4 | |
| Hydrochloric Acid SCHEMBL1375668 | 0.72 | PHF8 (0.61) | ALDH1A1CHRNB2CHRNB4CHRNA4PHF8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12404243-B2 | Inhibitors of the Wnt/beta-catenin pathway | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2025-09-02 | — | — | US | disclosed |
| EP-3749640-B1 | INHIBITORS OF THE WNT/BETA-CATENIN PATHWAY | UNIV CALIFORNIA (US) | 2025-07-16 | — | — | EP | disclosed |
| US-20240059654-A1 | INHIBITORS OF THE WNT/BETA-CATENIN PATHWAY | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2024-02-22 | — | — | US | disclosed |
| US-11708329-B2 | Inhibitors of the WNT/beta-catenin pathway | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2023-07-25 | — | — | US | disclosed |
| US-11708329-B2 | Inhibitors of the WNT/beta-catenin pathway | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2023-07-25 | — | — | US | disclosed |
| US-11708329-B2 | Inhibitors of the WNT/beta-catenin pathway | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2023-07-25 | — | — | US | disclosed |
| US-20210371384-A1 | INHIBITORS OF THE WNT/BETA-CATENIN PATHWAY | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2021-12-02 | — | — | US | disclosed |
| US-20210371384-A1 | INHIBITORS OF THE WNT/BETA-CATENIN PATHWAY | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2021-12-02 | — | — | US | disclosed |
| EP-3749640-A1 | INHIBITORS OF THE WNT/BETA-CATENIN PATHWAY | The Regents of the University of California (US) | 2020-12-16 | — | — | EP | disclosed |
| WO-2019152536-A1 | INHIBITORS OF THE WNT/BETA-CATENIN PATHWAY | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2019-08-08 | — | — | WO | disclosed |
| WO-2019152536-A1 | INHIBITORS OF THE WNT/BETA-CATENIN PATHWAY | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2019-08-08 | — | — | WO | disclosed |
| US-8889262-B2 | Methods and systems for delivering wood preservatives | EMPIRE TECHNOLOGY DEVELOPMENT LLC (US) | 2014-11-18 | — | — | US | disclosed |
| WO-2014014445-A1 | METHODS AND SYSTEMS FOR DELIVERING WOOD PRESERVATIVES | EMPIRE TECHNOLOGY DEVELOPMENT LLC (US) | 2014-01-23 | — | — | WO | disclosed |
| US-20140017506-A1 | METHODS AND SYSTEMS FOR DELIVERING WOOD PRESERVATIVES | EMPIRE TECHNOLOGY DEVELOPMENT LLC (US) | 2014-01-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11708329-B2 | Inhibitors of the WNT/beta-catenin pathway | CTNNB1, CTNNBL1, CTNND1 | ALDH1A1 2704/4885TSHR 4326/4885TP53 61/4885 |
| US-12404243-B2 | Inhibitors of the Wnt/beta-catenin pathway | CTNNB1, CTNNBL1, CTNND1 | ALDH1A1 2704/4885TSHR 4326/4885TP53 61/4885 |
| US-20210371384-A1 | INHIBITORS OF THE WNT/BETA-CATENIN PATHWAY | CTNNB1, CTNNBL1, CTNND1 | ALDH1A1 2704/4885TSHR 4326/4885TP53 61/4885 |
| US-20240059654-A1 | INHIBITORS OF THE WNT/BETA-CATENIN PATHWAY | CTNNB1, CTNNBL1, CTNND1 | ALDH1A1 2704/4885TSHR 4326/4885TP53 61/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.